PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2178890
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2178890
According to Stratistics MRC, the Global Pet Aromatherapy Market is accounted for $0.1 billion in 2026 and is expected to reach $0.2 billion by 2034 growing at a CAGR of 9.1% during the forecast period. The market covers animal-marketed aromatic products intended to support comfort during routine care or stressful situations, including pet-formulated sprays and topical blends. It is used to provide sensory enrichment or relaxation as an adjunct to appropriate veterinary and behaviour care. Growth reflects demand for natural-positioned pet products and home-based wellness routines. Adoption will also depend on product reliability, affordability, professional guidance and availability through established distribution channels.
Interest in home-based wellness and scent-oriented calming products
Growing interest in home-based wellness and natural-positioned calming products is supporting pet aromatherapy. Owners seek pet-safe sprays, balms and grooming aromatics to support relaxation during travel, grooming and routine care. Aromatherapy is positioned as a gentle adjunct to behavior and veterinary care. Premiumization of pet wellness and demand for low-handling alternatives support trial. Retail and online availability, plus education on safe use, are expanding awareness. However, species-specific safety remains central to credible positioning.
Species-specific toxicity and limited efficacy evidence
Adoption is constrained by species-specific toxicity risks, particularly essential oils harmful to cats, and by limited efficacy evidence. Owners may misuse human products or apply inappropriate concentrations. Veterinarians may hesitate to recommend unverified products. Regulatory oversight of aromatic claims varies. Product quality and purity differ widely. Clear safety labeling, veterinarian-reviewed guidance and species-appropriate formulations are essential to reduce risk and build trust.
Veterinarian-reviewed guidance and safer product design
Opportunity lies in veterinarian-reviewed guidance, safer formulations and species-specific product design. Education on dilution, application and contraindications supports responsible use. Partnerships with integrative veterinarians and behaviorists lend credibility. Low-aroma and unscented options address sensitivity. Bundled wellness kits and grooming integrations expand use occasions. Transparent sourcing and safety testing differentiate premium brands. Digital education and clear labeling can broaden adoption while reducing risk.
Toxicity incidents and unsupported therapeutic claims
The market faces risks from toxicity incidents, adverse reactions and unsupported therapeutic claims. A single high-profile case can damage category trust. Regulatory scrutiny of aromatic and calming claims is increasing. Low-cost, poorly labeled products and human aromatherapy cross-over create safety risks. Competition from pheromone diffusers and calming supplements pressures differentiation. Companies need rigorous safety testing, clear warnings and responsible marketing to protect pets and reputation.
The COVID-19 pandemic disrupted veterinary appointments, specialist retail, travel and pet-care supply chains, while shifting more purchasing and advice-seeking online. Some owners postponed non-urgent services, but increased time at home and heightened attention to animal wellbeing supported demand for home-use products and digital support. Providers responded with e-commerce, teleconsultation and flexible scheduling. As restrictions eased, in-person services recovered, but demand for convenience and clear product information remained. The effect varied by market, depending on clinical need, discretionary spending and reliance on in-person experiences where available.
The Pet-Safe Aromatic Sprays segment is expected to be the largest during the forecast period
The Pet-Safe Aromatic Sprays segment is expected to account for a leading share of the pet aromatherapy market during the forecast period. Its position reflects the relevance of this group to the addressable companion-animal population and the breadth of use across the market's principal product form applications. Established product availability, owner familiarity and professional recommendations support demand, while a wide range of care needs encourages repeat purchasing or service use. Market participants are expected to prioritize this segment through targeted product development, broader distribution and clearer use guidance.
The Odor and Ambient Freshness segment is expected to have the highest CAGR during the forecast period
The Odor and Ambient Freshness segment is expected to have the highest CAGR during the forecast period as providers expand targeted solutions and improve access through veterinary, specialist retail and digital channels. Demand is supported by growing awareness of the relevant need, improved product formulation or service delivery, and increased owner willingness to invest in tailored companion-animal care. As evidence, convenience and availability improve, this segment may attract new entrants and encourage established providers to broaden their portfolios.
North America is expected to account for a leading share of the pet aromatherapy market, supported by high companion-animal ownership, comparatively developed veterinary infrastructure, established pet specialty retail and relatively high per-pet expenditure. The United States represents a major demand center because owners have access to veterinary clinics, online pet-care platforms and a broad selection of specialized products and services. Canada contributes through a mature pet-care ecosystem and established companion-animal health providers. Market adoption is also supported by insurance availability, consumer awareness and product innovation, although adoption differs by income, geography and veterinary access.
Asia Pacific is expected to exhibit strong growth in the pet aromatherapy market as pet ownership, urban household formation, veterinary service availability and organized pet retail expand across major markets. China, Japan, South Korea, India and Australia offer different adoption pathways, reflecting differences in purchasing power, veterinary infrastructure, product regulation and the role of digital commerce. Growing awareness of preventive care and rising demand for premium companion-animal products are likely to support market development. Expansion will depend on localized products, professional education and compliance with national animal-health and consumer-protection requirements.
Key players in the market
Some of the key players in the Global Pet Aromatherapy Market include Earth Heart, Inc., AnimalEO, Aromadog, Pet Remedy Ltd., The Anxious Pet, Only Natural Pet, Wondercide, Skout's Honor, Vet's Best, TropiClean, Earthbath, Herbal Dog Co., Aroma Paws, Pet House, Natural Dog Company.
In October 2026, Pet Remedy was formally presented with The King's Award for Enterprise in Innovation, recognising its patented natural valerian-based calming technology and commercial success.
In September 2026, Pet Remedy's managing director detailed the company's 12 published studies and 15 years of trials in an SME Leaders interview, reinforcing the evidence base behind its aromatherapy calming products.
In May 2026, Pet Remedy's calming diffuser was reviewed as a widely stocked, low-cost valerian-based aromatherapy option for dogs in the UK market.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.